Matt Abernethy, CFO: Neurocrine Biosciences NBIX Sell · Filed 24/07/18

Trade details

Type: Insider sale
Amount: $135,036
Shares · price: 900 sh · $150.04 a share
Held after: 31,528 sh
Stock: Neurocrine Biosciences NBIX
Person: Matt AbernethyCFO
Trade date: 24/07/16
Filed: 24/07/18
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/06/16~24/08/15

Matt Abernethy's recent trades

Matt AbernethyOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$361K
2,311 sh
$361K
Filed 09/14
Traded 09/14
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$140.9K
1,206 sh
$140.9K
Filed 25/02/14
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$158.4K
1,352 sh
$158.4K
Filed 25/02/13
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$141.3K
1,206 sh
$141.3K
Filed 25/02/13
Traded 25/02/13